➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
AstraZeneca
Harvard Business School
McKesson
Moodys

Last Updated: September 26, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR SODIUM LACTATE 0.167 MOLAR IN PLASTIC CONTAINER

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

All Clinical Trials for Sodium Lactate 0.167 Molar In Plastic Container

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00168519 ↗ Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes Completed Diabetes Australia N/A 2002-10-01 The purpose of this project is to determine whether glucose metabolism can be improved by administering a substance (nitric oxide donor) normally released by muscles during exercise.
NCT00168519 ↗ Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes Completed Hoffmann-La Roche N/A 2002-10-01 The purpose of this project is to determine whether glucose metabolism can be improved by administering a substance (nitric oxide donor) normally released by muscles during exercise.
NCT00168519 ↗ Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes Completed National Health and Medical Research Council, Australia N/A 2002-10-01 The purpose of this project is to determine whether glucose metabolism can be improved by administering a substance (nitric oxide donor) normally released by muscles during exercise.
NCT00168519 ↗ Contraction (Exercise) Mediated Glucose Uptake as a Therapeutic Target in Type 2 Diabetes Completed Baker Heart Research Institute N/A 2002-10-01 The purpose of this project is to determine whether glucose metabolism can be improved by administering a substance (nitric oxide donor) normally released by muscles during exercise.
NCT00279617 ↗ Levetiracetam Treatment of Panic Disorder and Lactate-Induced Panic Attacks Completed UCB Pharma Phase 3 2006-01-01 The main purpose of this research study is to determine whether the drug Levetiracetam (Keppra™) is effective in the prevention of panic attacks. The drug Levetiracetam (Keppra™) has been approved for the treatment of seizures by the U.S. Federal Food and Drug Administration (FDA) and is available by prescription. Levetiracetam has not been approved by the FDA for the treatment of panic disorder.
NCT00279617 ↗ Levetiracetam Treatment of Panic Disorder and Lactate-Induced Panic Attacks Completed University of Cincinnati Phase 3 2006-01-01 The main purpose of this research study is to determine whether the drug Levetiracetam (Keppra™) is effective in the prevention of panic attacks. The drug Levetiracetam (Keppra™) has been approved for the treatment of seizures by the U.S. Federal Food and Drug Administration (FDA) and is available by prescription. Levetiracetam has not been approved by the FDA for the treatment of panic disorder.
NCT00279617 ↗ Levetiracetam Treatment of Panic Disorder and Lactate-Induced Panic Attacks Completed Lindner Center of HOPE Phase 3 2006-01-01 The main purpose of this research study is to determine whether the drug Levetiracetam (Keppra™) is effective in the prevention of panic attacks. The drug Levetiracetam (Keppra™) has been approved for the treatment of seizures by the U.S. Federal Food and Drug Administration (FDA) and is available by prescription. Levetiracetam has not been approved by the FDA for the treatment of panic disorder.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Sodium Lactate 0.167 Molar In Plastic Container

Condition Name

Condition Name for Sodium Lactate 0.167 Molar In Plastic Container
Intervention Trials
Lactate 3
Hyperlactatemia 3
Intoxication 2
Covid19 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Sodium Lactate 0.167 Molar In Plastic Container
Intervention Trials
Shock 6
Wounds and Injuries 5
Brain Injuries 5
Heart Failure 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Sodium Lactate 0.167 Molar In Plastic Container

Trials by Country

Trials by Country for Sodium Lactate 0.167 Molar In Plastic Container
Location Trials
United States 8
Indonesia 5
Uzbekistan 4
Ukraine 4
France 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Sodium Lactate 0.167 Molar In Plastic Container
Location Trials
California 2
Pennsylvania 1
Florida 1
Connecticut 1
Nevada 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Sodium Lactate 0.167 Molar In Plastic Container

Clinical Trial Phase

Clinical Trial Phase for Sodium Lactate 0.167 Molar In Plastic Container
Clinical Trial Phase Trials
Phase 4 18
Phase 3 11
Phase 2/Phase 3 5
[disabled in preview] 16
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Sodium Lactate 0.167 Molar In Plastic Container
Clinical Trial Phase Trials
Recruiting 22
Not yet recruiting 20
Completed 14
[disabled in preview] 9
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Sodium Lactate 0.167 Molar In Plastic Container

Sponsor Name

Sponsor Name for Sodium Lactate 0.167 Molar In Plastic Container
Sponsor Trials
Innogene Kalbiotech Pte. Ltd 5
Yuria-Pharm 4
Institut d'Anesthesiologie des Alpes Maritimes 3
[disabled in preview] 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Sodium Lactate 0.167 Molar In Plastic Container
Sponsor Trials
Other 68
Industry 17
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Moodys
Baxter
Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.